Efficacy and Safety of Three Cryotherapy Devices for Wart Treatment: A Randomized, Controlled, Investigator-Blinded, Comparative Study

Imko Walczuk, Frank Eertmans, Bart Rossel, Agnieszka Cegielska, Eggert Stockfleth, Andre Antunes, Els Adriaens, Imko Walczuk, Frank Eertmans, Bart Rossel, Agnieszka Cegielska, Eggert Stockfleth, Andre Antunes, Els Adriaens

Abstract

Introduction: Cutaneous warts are common skin lesions, caused by human papillomavirus. For years, liquid nitrogen is the cryogen of choice for wart treatment. Alternatively, several cryogenic devices for home treatment are commercially available. The present trial assessed efficacy and safety of a novel nitrous oxide-based cryogenic device for home use (EndWarts Freeze® in Europe, Compound W® Nitro-Freeze in the USA).

Methods: This investigator-blinded, controlled, randomized study compared the nitrous oxide device (test product) with a dimethylether propane-based product (Wartner®; comparator 1). Subjects with common or plantar warts (50/50 ratio) were randomized into two groups (n = 58, test product; n = 40, comparator 1). Sequentially, an extra treatment arm (n = 40) was added to compare with a dimethylether-based product with metal nib (Wortie®; comparator 2). Main objective implied comparison of the percentage cured subjects after one to maximum three treatments. Efficacy and safety was evaluated by a blinded investigator.

Results: After a maximum of three applications, a significantly (p = 0.001) higher cure rate of 70.7% (Intention-to-Treat analysis) was observed with test product versus 46.2% (comparator 1) and 47.5% (comparator 2). Almost three times more subjects were cured after 1 test product application (29.3%), versus comparator 1 (10.4%) and comparator 2 (12.5%). Reported side effects were transient and typical of cryotherapy. All treatments were well-tolerated.

Conclusion: The superior cure rates for the test product versus two comparators can be explained by its design. Combination of nitrous oxide (cooling agent), the specific activation method (holding the liquid coolant in the cap), and skin-conforming polyurethane foam, results in higher cooling efficiency (- 80 °C) and more effective wart freezing. This trial demonstrated that the nitrous oxide device is a safe, user-friendly and effective wart treatment for home use, comparing favourably to dimethylether (propane) devices with higher freezing temperature, regardless of the applicator type.

Funding: Oystershell Laboratories.

Trial registration: Clinicaltrials.gov identifier, NCT03129373.

Keywords: Cryotherapy; Dimethylether (propane); Home treatment; Nitrous oxide; Prescription-free; Warts.

Figures

Fig. 1
Fig. 1
Inclusion and exclusion criteria
Fig. 2
Fig. 2
CONSORT flow chart (ITT population)
Fig. 3
Fig. 3
CONSORT flow chart (PP population)

References

    1. Tschandl P, Rosendahl C, Kittler H. Cutaneous human papillomavirus infection: manifestations and diagnosis. Curr Probl Dermatol. 2014;45:92–97. doi: 10.1159/000355966.
    1. Ahmed I, Agarwal S, Ilchyshyn A, Charles-Holmes S, Berth-Jones J. Liquid nitrogen cryotherapy of common warts: cryo-spray vs. cotton wool bud. Br J Dermatol. 2001;144:1006–1009. doi: 10.1046/j.1365-2133.2001.04190.x.
    1. Dall’oglio F, D’Amico V, Nasca MR, Micali G. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13:73–96. doi: 10.2165/11594610-000000000-00000.
    1. Cooper SM, Dawber RP. The history of cryosurgery. J R Soc Med. 2001;94:196–201. doi: 10.1177/014107680109400416.
    1. Freiman A, Bouganim N. History of cryotherapy. Dermatol Online J. 2005;11:9.
    1. Bruggink SC, Gussekloo J, Berger MY, Zaaijer K, Assendelft WJ, de Waal MW, et al. Cryotherapy with liquid nitrogen versus topical salicylic acid application for cutaneous warts in primary care: randomized controlled trial. CMAJ. 2010;182:1624–1630. doi: 10.1503/cmaj.092194.
    1. Steele K, Irwin WG. Liquid nitrogen and salicylic/lactic acid paint in the treatment of cutaneous warts in general practice. J R Coll Gen Pract. 1988;38:256–258.
    1. Berth-Jones J, Hutchinson PE. Modern treatment of warts: cure rates at 3 and 6 months. Br J Dermatol. 1992;127:262–265. doi: 10.1111/j.1365-2133.1992.tb00125.x.
    1. Erkens AMJL, Kuijpers RJAM, Knottnerus JA. Treatment of verrucae vulgares in general practice: a randomized controlled trial on the effectiveness of liquid nitrogen and the Histofreezer. J Dermatol Treat. 1992;3:193–196. doi: 10.3109/09546639209088722.
    1. Krunic AL. Theoretical principles of immunocryosurgery. In: Pasquali P, editor. Cryosurgery: a practical manual. Berlin: Springer-Verlag; 2014. pp. 33–48.
    1. Andrews MD. Cryosurgery for common skin conditions. Am Fam Physician. 2004;69:2365–2372.
    1. Buckley D. Cryotherapy for warts. In: Pasquali P, editor. Cryosurgery: a practical manual. Berlin: Springer-Verlag; 2014. pp. 107–119.
    1. Dawber RPR, Colver G, Pringle F, Jackson A. Cutaneous cryosurgery: principles and clinical practice. 2. London: Martin Dunitz; 1997. pp. 28–36.
    1. Yiu W, Basco MT, Aruny JE, Cheng SWK, Sumpio BE. Cryosurgery: a review. Int J Angiol. 2007;16:1–6. doi: 10.1055/s-0031-1278235.
    1. Burkhart CG, Pchalek I, Adler M, Burkhart CN. An in vitro study comparing temperatures of over-the-counter wart preparations with liquid nitrogen. J Am Acad Dermatol. 2007;57:1019–1020. doi: 10.1016/j.jaad.2007.06.037.
    1. Winkler JL, Jeronimo J, Singleton J, Janmohamed A, Santos C. Performance of cryotherapy devices using nitrous oxide and carbon dioxide. Int J Gynaecol Obstet. 2010;111:73–77. doi: 10.1016/j.ijgo.2010.04.032.
    1. Maiti H, Cheyne MF, Hobbs G, Jerai HA. Cryotherapy gas—to use nitrous oxide or carbon dioxide. Int J STD AIDS. 1999;10:118–120.
    1. Costello JT, Culligan K, Selfe J, Dennelly AE. Muscle, skin and core temperature after – 110 °C cold air and 8 °C water treatment. PLoS One. 2012;7:e48910. doi: 10.1371/journal.pone.0048910.
    1. Thermal conductivity of common materials and gases. Available from: . Accessed Nov 2017.
    1. Caballero Martínez F, Plaza Nohales C, Pérez Canal C, Lucena Martín MJ, Holgado Catalán M, Olivera Cañadas G. Cutaneous cryosurgery in family medicine: dimethyl ether-propane spray versus liquid nitrogen. Aten Primaria. 1996;18:211–216.
    1. Nguyen NV, Burkhart CG. Cryosurgical treatment of warts: dimethyl ether and propane versus liquid nitrogen—case report and review of the literature. J Drugs Dermatol. 2011;10:1174–1176.
    1. Sterling JC, Handfield-Jones S, Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001;144:4–11. doi: 10.1046/j.1365-2133.2001.04066.x.
    1. Gibbs S, Harvey I, Sterling JC, Stark R. Local treatments for cutaneous warts. Cochrane Database Syst Rev. 2004;4:CD001781.
    1. Bacelieri R, Johnson SM. Cutaneous warts: an evidence-based approach to therapy. Am Fam Physician. 2005;72:647–652.
    1. Bencini PL, Guida S, Cazzaniga S, Pellacani G, Galimberti MG, Bencini M, Naldi L. Risk factors for recurrence after successful treatment of warts: the role of smoking habits. J Eur Acad Dermatol Venereol. 2017;31:712–716. doi: 10.1111/jdv.14086.
    1. Sultana R, Alam M, Khondker L, Ahamed RS. Safety in use of cryotherapy and topical salicylic acid with lactic acid combination in treating verruca vulgaris. Mymensingh Med J. 2012;21:715–722.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever